Nanosphere's Q3 Revenues Shrink; Loss Swells On Increased Costs, One-Time Charge | GenomeWeb
NEW YORK (GenomeWeb News) - Nanosphere yesterday said third-quarter revenues fell 58 percent as R&D spending rose 37 percent and its net loss ballooned.
 
Total receipts for the three months ended Sept. 30 decreased to $199,000 from $468,500 year over year.
 
The company said product-related revenue fell to $6,125 from $89,030, and grant and contract revenue fell to $192,880 from $379,494.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.